LORATADINE

LORATADINE was reported 108750 times

These side effects are most commonly reported by patients taking LORATADINE:

# Side effect Count
0 DRUG INEFFECTIVE 13170
1 FATIGUE 6784
2 NAUSEA 5983
3 HEADACHE 5465
4 DIARRHOEA 4927
5 DYSPNOEA 4917
6 OFF LABEL USE 4717
7 DIZZINESS 4447
8 PAIN 4168
9 RASH 3525
10 PRURITUS 3469
11 COUGH 3178
12 VOMITING 3054
13 SOMNOLENCE 2987
14 ARTHRALGIA 2960
15 ASTHENIA 2780
16 PNEUMONIA 2772
17 ANXIETY 2724
18 MALAISE 2697
19 INSOMNIA 2641
20 PYREXIA 2392
21 FALL 2385
22 PAIN IN EXTREMITY 2317
23 URTICARIA 2209
24 FEELING ABNORMAL 2144
25 DEPRESSION 2117
26 PRODUCT USE ISSUE 2102
27 BACK PAIN 2083
28 WEIGHT DECREASED 2048
29 CONDITION AGGRAVATED 1980
30 PRODUCT USE IN UNAPPROVED INDICATION 1945
31 DEATH 1942
32 CONSTIPATION 1935
33 HYPERSENSITIVITY 1933
34 CHEST PAIN 1744
35 PRODUCT DOSE OMISSION ISSUE 1728
36 ABDOMINAL PAIN UPPER 1726
37 EXTRA DOSE ADMINISTERED 1666
38 CHRONIC KIDNEY DISEASE 1661
39 HYPERTENSION 1649
40 WEIGHT INCREASED 1646
41 SINUSITIS 1625
42 DECREASED APPETITE 1603
43 URINARY TRACT INFECTION 1593
44 MUSCLE SPASMS 1589
45 NASOPHARYNGITIS 1565
46 ASTHMA 1558
47 ABDOMINAL PAIN 1553
48 ERYTHEMA 1543
49 BLOOD PRESSURE INCREASED 1512
50 INCORRECT DOSE ADMINISTERED 1465
51 ABDOMINAL DISCOMFORT 1451
52 DRUG HYPERSENSITIVITY 1437
53 COVID-19 1401
54 RENAL FAILURE 1376
55 ACUTE KIDNEY INJURY 1366
56 GASTROOESOPHAGEAL REFLUX DISEASE 1338
57 PERIPHERAL SWELLING 1311
58 OVERDOSE 1305
59 GAIT DISTURBANCE 1296
60 PARAESTHESIA 1288
61 INJECTION SITE PAIN 1284
62 MYALGIA 1268
63 PALPITATIONS 1236
64 ANAEMIA 1225
65 HYPOTENSION 1208
66 EXPIRED PRODUCT ADMINISTERED 1203
67 TREMOR 1197
68 HYPOAESTHESIA 1170
69 ALOPECIA 1168
70 CHEST DISCOMFORT 1117
71 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1106
72 HEART RATE INCREASED 1087
73 RHINORRHOEA 1080
74 VISION BLURRED 1079
75 DEHYDRATION 1070
76 OROPHARYNGEAL PAIN 1056
77 CHILLS 1025
78 BRONCHITIS 1021
79 CONFUSIONAL STATE 1019
80 NASAL CONGESTION 1016
81 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1007
82 OEDEMA PERIPHERAL 984
83 HYPERHIDROSIS 978
84 INFLUENZA 959
85 FLUSHING 942
86 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 928
87 DRY MOUTH 928
88 MEMORY IMPAIRMENT 914
89 MIGRAINE 912
90 DYSPEPSIA 909
91 NEUROPATHY PERIPHERAL 879
92 DRY SKIN 871
93 THERAPEUTIC RESPONSE UNEXPECTED 861
94 WHITE BLOOD CELL COUNT DECREASED 847
95 ILLNESS 845
96 LOSS OF CONSCIOUSNESS 821
97 EPISTAXIS 815
98 INFECTION 812
99 SWELLING FACE 800
100 DRUG INTERACTION 796
101 PLATELET COUNT DECREASED 794
102 ABDOMINAL DISTENSION 791
103 CONTUSION 773
104 DRUG EFFECT INCOMPLETE 771
105 JOINT SWELLING 764
106 ATRIAL FIBRILLATION 760
107 MUSCULAR WEAKNESS 760
108 DRUG DOSE OMISSION 758
109 SYNCOPE 756
110 WHEEZING 739
111 SEPSIS 738
112 BLOOD GLUCOSE INCREASED 723
113 DRUG EFFECT DECREASED 722
114 BALANCE DISORDER 714
115 DYSPHAGIA 712
116 CEREBROVASCULAR ACCIDENT 707
117 HOT FLUSH 697
118 SWELLING 695
119 UPPER RESPIRATORY TRACT INFECTION 691
120 ARTHRITIS 690
121 EMOTIONAL DISTRESS 689
122 VISUAL IMPAIRMENT 684
123 HAEMOGLOBIN DECREASED 680
124 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 677
125 MYOCARDIAL INFARCTION 677
126 THROAT IRRITATION 676
127 DYSGEUSIA 659
128 PULMONARY EMBOLISM 659
129 SEIZURE 659
130 PSORIASIS 655
131 SUICIDAL IDEATION 652
132 SLEEP DISORDER 636
133 PRODUCT QUALITY ISSUE 634
134 BONE PAIN 633
135 NO ADVERSE EVENT 631
136 STRESS 627
137 ANAPHYLACTIC REACTION 617
138 ACCIDENTAL OVERDOSE 613
139 UNEVALUABLE EVENT 611
140 HOSPITALISATION 610
141 INFUSION RELATED REACTION 603
142 INJECTION SITE ERYTHEMA 593
143 PRODUCTIVE COUGH 585
144 FEELING HOT 581
145 TACHYCARDIA 575
146 DYSPHONIA 567
147 BURNING SENSATION 557
148 CARDIAC FAILURE CONGESTIVE 556
149 FEBRILE NEUTROPENIA 556
150 RASH PRURITIC 555
151 INFLUENZA LIKE ILLNESS 553
152 SKIN EXFOLIATION 549
153 OXYGEN SATURATION DECREASED 542
154 MUSCULOSKELETAL STIFFNESS 538
155 NECK PAIN 536
156 LETHARGY 534
157 AGITATION 531
158 DEEP VEIN THROMBOSIS 531
159 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 524
160 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 522
161 NERVOUSNESS 517
162 SNEEZING 517
163 INJURY 515
164 DIABETES MELLITUS 509
165 DISEASE PROGRESSION 508
166 NEUTROPENIA 507
167 SEASONAL ALLERGY 506
168 LACRIMATION INCREASED 504
169 DISCOMFORT 502
170 GASTROINTESTINAL HAEMORRHAGE 502
171 DRY EYE 501
172 CELLULITIS 499
173 GASTROINTESTINAL DISORDER 499
174 END STAGE RENAL DISEASE 498
175 ANGIOEDEMA 495
176 EYE PAIN 491
177 HALLUCINATION 491
178 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 485
179 DISTURBANCE IN ATTENTION 483
180 FLATULENCE 483
181 OSTEOARTHRITIS 477
182 THROMBOSIS 477
183 INTENTIONAL PRODUCT USE ISSUE 475
184 VERTIGO 475
185 LIP SWELLING 470
186 RHEUMATOID ARTHRITIS 469
187 HAEMORRHAGE 467
188 BLOOD PRESSURE DECREASED 466
189 STOMATITIS 459
190 AMNESIA 456
191 PNEUMONIA ASPIRATION 452
192 IRRITABILITY 446
193 CATARACT 443
194 EYE SWELLING 442
195 DERMATITIS ATOPIC 440
196 ECZEMA 438
197 DRUG INTOLERANCE 437
198 RESPIRATORY FAILURE 434
199 TINNITUS 434
200 COMA 433
201 BLOOD CHOLESTEROL INCREASED 429
202 HEPATIC ENZYME INCREASED 428
203 MUSCULOSKELETAL PAIN 428
204 OSTEOPOROSIS 428
205 ADVERSE DRUG REACTION 426
206 EYE PRURITUS 424
207 FLUID RETENTION 424
208 CARDIAC DISORDER 422
209 DEPRESSED MOOD 422
210 RENAL INJURY 417
211 ALANINE AMINOTRANSFERASE INCREASED 413
212 THROMBOCYTOPENIA 410
213 DYSPNOEA EXERTIONAL 409
214 EYE IRRITATION 408
215 PLEURAL EFFUSION 408
216 INTENTIONAL PRODUCT MISUSE 402
217 THERAPEUTIC RESPONSE DECREASED 401
218 OEDEMA 398
219 BLISTER 396
220 UNDERDOSE 389
221 INJECTION SITE BRUISING 385
222 INJECTION SITE SWELLING 385
223 RASH ERYTHEMATOUS 382
224 BLOOD CREATININE INCREASED 379
225 OCULAR HYPERAEMIA 379
226 NEPHROLITHIASIS 375
227 SWOLLEN TONGUE 375
228 HERPES ZOSTER 374
229 MOBILITY DECREASED 372
230 SLEEP APNOEA SYNDROME 372
231 TOXICITY TO VARIOUS AGENTS 372
232 INJECTION SITE PRURITUS 370
233 SURGERY 370
234 PRODUCT DOSE OMISSION 368
235 RENAL IMPAIRMENT 366
236 SINUS DISORDER 365
237 POLLAKIURIA 363
238 HYPOKALAEMIA 358
239 EAR INFECTION 357
240 GENERAL PHYSICAL HEALTH DETERIORATION 355
241 ACNE 354
242 BLOOD POTASSIUM DECREASED 353
243 CHOLELITHIASIS 351
244 SPEECH DISORDER 349
245 CRYING 348
246 SKIN BURNING SENSATION 348
247 SKIN DISCOLOURATION 348
248 PANIC ATTACK 345
249 RENAL DISORDER 345
250 THROAT TIGHTNESS 338
251 DYSURIA 337
252 AGGRESSION 336
253 ARTHROPATHY 336
254 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 336
255 ASPARTATE AMINOTRANSFERASE INCREASED 334
256 ANHEDONIA 333
257 RASH MACULAR 331
258 CARDIAC ARREST 326
259 INFLAMMATION 323
260 HYPOXIA 321
261 INFUSION SITE PAIN 320
262 THERAPY INTERRUPTED 320
263 DEVICE ISSUE 319
264 CONVULSION 318
265 VIRAL INFECTION 315
266 RED BLOOD CELL COUNT DECREASED 314
267 TYPE 2 DIABETES MELLITUS 313
268 WHITE BLOOD CELL COUNT INCREASED 308
269 PAIN IN JAW 305
270 COGNITIVE DISORDER 304
271 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 304
272 POOR QUALITY SLEEP 304
273 SUICIDE ATTEMPT 303
274 ABNORMAL BEHAVIOUR 302
275 THERAPY CESSATION 302
276 MATERNAL EXPOSURE DURING PREGNANCY 301
277 MULTIPLE SCLEROSIS RELAPSE 300
278 HYPERSOMNIA 296
279 ADVERSE EVENT 292
280 INJECTION SITE REACTION 292
281 NIGHT SWEATS 292
282 ACCIDENTAL EXPOSURE TO PRODUCT 290
283 HYPONATRAEMIA 290
284 LIMB DISCOMFORT 290
285 PRODUCT SUBSTITUTION ISSUE 288
286 NEPHROGENIC ANAEMIA 287
287 MALIGNANT NEOPLASM PROGRESSION 285
288 CARDIAC FAILURE 284
289 DYSARTHRIA 284
290 HAEMATOCHEZIA 283
291 THERAPEUTIC RESPONSE SHORTENED 282
292 EAR PAIN 281
293 HYPOTHYROIDISM 281
294 MENTAL DISORDER 281
295 LYMPHADENOPATHY 278
296 INTENTIONAL OVERDOSE 277
297 DYSKINESIA 274
298 LUNG DISORDER 274
299 ANGER 273
300 NEUTROPHIL COUNT DECREASED 272
301 NIGHTMARE 270
302 CYSTITIS 269
303 LIMB INJURY 267
304 FEELING COLD 266
305 GASTRITIS 263
306 CORONARY ARTERY DISEASE 261
307 THERAPEUTIC PRODUCT EFFECT DECREASED 261
308 TRANSIENT ISCHAEMIC ATTACK 261
309 SKIN DISORDER 260
310 ORAL PAIN 258
311 FUNGAL INFECTION 257
312 DIVERTICULITIS 256
313 RECTAL HAEMORRHAGE 255
314 PANCREATITIS 254
315 RESPIRATORY TRACT INFECTION 254
316 ROAD TRAFFIC ACCIDENT 254
317 HEAD DISCOMFORT 252
318 MIDDLE INSOMNIA 252
319 DISEASE RECURRENCE 251
320 SINUS CONGESTION 250
321 TREATMENT NONCOMPLIANCE 249
322 GASTRIC DISORDER 247
323 ARRHYTHMIA 245
324 FEELING JITTERY 245
325 MOOD SWINGS 245
326 NEURALGIA 245
327 BLOOD GLUCOSE DECREASED 244
328 INJECTION SITE HAEMORRHAGE 244
329 HAEMOPTYSIS 242
330 HEAD INJURY 242
331 MENTAL STATUS CHANGES 242
332 DYSSTASIA 241
333 URINARY INCONTINENCE 240
334 THERAPY NON-RESPONDER 239
335 INTERVERTEBRAL DISC PROTRUSION 238
336 LOWER RESPIRATORY TRACT INFECTION 238
337 COMPLETED SUICIDE 237
338 DEVICE MALFUNCTION 236
339 PULMONARY OEDEMA 236
340 PRE-EXISTING CONDITION IMPROVED 235
341 EXPOSURE DURING PREGNANCY 234
342 DISORIENTATION 233
343 STAPHYLOCOCCAL INFECTION 232
344 URINARY RETENTION 232
345 ABNORMAL DREAMS 230
346 EYE DISORDER 230
347 EMOTIONAL DISORDER 229
348 HEART RATE IRREGULAR 229
349 ILL-DEFINED DISORDER 229
350 ECONOMIC PROBLEM 228
351 FIBROMYALGIA 228
352 IMPAIRED QUALITY OF LIFE 228
353 RESTLESS LEGS SYNDROME 228
354 RESTLESSNESS 228
355 BLOOD ALKALINE PHOSPHATASE INCREASED 226
356 SKIN LESION 226
357 PANCYTOPENIA 225
358 OSTEOPENIA 223
359 BRADYCARDIA 222
360 MOOD ALTERED 222
361 MULTIPLE ALLERGIES 222
362 VAGINAL HAEMORRHAGE 222
363 RENAL FAILURE ACUTE 221
364 RESPIRATORY DISORDER 221
365 CROHN^S DISEASE 220
366 GALLBLADDER DISORDER 220
367 RESPIRATORY TRACT CONGESTION 220
368 PRODUCT DOSE OMISSION IN ERROR 218
369 PSORIATIC ARTHROPATHY 215
370 BONE DENSITY DECREASED 214
371 INFUSION SITE ERYTHEMA 213
372 INTESTINAL OBSTRUCTION 213
373 PRURITUS GENERALISED 213
374 HYPERLIPIDAEMIA 212
375 MULTIPLE SCLEROSIS 211
376 PRODUCT TASTE ABNORMAL 210
377 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 209
378 GASTROENTERITIS VIRAL 209
379 PSYCHOMOTOR HYPERACTIVITY 208
380 IRRITABLE BOWEL SYNDROME 207
381 PRODUCT PRESCRIBING ISSUE 207
382 HEART RATE DECREASED 206
383 RETCHING 206
384 FULL BLOOD COUNT DECREASED 205
385 IMPAIRED HEALING 205
386 MEDICATION ERROR 205
387 SKIN IRRITATION 205
388 UPPER-AIRWAY COUGH SYNDROME 205
389 HIATUS HERNIA 204
390 HYPERGLYCAEMIA 203
391 COLITIS 202
392 GAIT INABILITY 202
393 HAEMORRHOIDS 202
394 LIVER DISORDER 202
395 PRESYNCOPE 200
396 HYPOACUSIS 198
397 JOINT STIFFNESS 198
398 PNEUMONITIS 198
399 ACUTE RESPIRATORY FAILURE 197
400 MUSCULOSKELETAL DISCOMFORT 197
401 ACUTE MYOCARDIAL INFARCTION 196
402 BREAST CANCER 196
403 HAEMATOCRIT DECREASED 196
404 INJECTION SITE RASH 195
405 DERMATITIS CONTACT 194
406 PHOTOPHOBIA 194
407 PHOTOSENSITIVITY REACTION 194
408 MOVEMENT DISORDER 193
409 SPINAL OSTEOARTHRITIS 193
410 HEPATIC STEATOSIS 192
411 HYPOGLYCAEMIA 192
412 PULMONARY HYPERTENSION 191
413 FEAR 190
414 RASH PAPULAR 190
415 PLASMA CELL MYELOMA 189
416 SEPTIC SHOCK 189
417 THIRST 189
418 TOOTHACHE 189
419 LABORATORY TEST ABNORMAL 188
420 DRUG WITHDRAWAL SYNDROME 187
421 FOOT FRACTURE 186
422 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 186
423 CHROMATURIA 185
424 TUBULOINTERSTITIAL NEPHRITIS 185
425 AGEUSIA 184
426 CARPAL TUNNEL SYNDROME 183
427 MUSCLE TIGHTNESS 183
428 HAEMATURIA 181
429 RASH GENERALISED 181
430 WITHDRAWAL SYNDROME 181
431 ANGINA PECTORIS 180
432 APHASIA 180
433 VITAMIN D DEFICIENCY 178
434 PARAESTHESIA ORAL 177
435 RIB FRACTURE 177
436 TOOTH DISORDER 177
437 ANKLE FRACTURE 176
438 CHOLECYSTITIS CHRONIC 176
439 OBESITY 176
440 HYPOPHAGIA 175
441 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 175
442 INFUSION SITE SWELLING 175
443 LIVER FUNCTION TEST ABNORMAL 175
444 DIPLOPIA 174
445 CONJUNCTIVITIS 173
446 DRY THROAT 173
447 DRUG EFFECT DELAYED 172
448 LOCALISED INFECTION 172
449 WRONG TECHNIQUE IN DRUG USAGE PROCESS 172
450 BLOOD PRESSURE FLUCTUATION 171
451 GOUT 171
452 HIP FRACTURE 171
453 CHOKING 170
454 INTENTIONAL DOSE OMISSION 170
455 LEUKOPENIA 170
456 BRAIN FOG 169
457 SEDATION 169
458 DRUG ADMINISTRATION ERROR 168
459 HAIR TEXTURE ABNORMAL 168
460 MUSCLE TWITCHING 168
461 CLOSTRIDIUM DIFFICILE INFECTION 167
462 BLOOD PRESSURE ABNORMAL 166
463 HAIR COLOUR CHANGES 165
464 INJECTION SITE URTICARIA 165
465 NEOPLASM MALIGNANT 165
466 PHARYNGEAL OEDEMA 165
467 ELECTROCARDIOGRAM QT PROLONGED 164
468 BLOOD URINE PRESENT 163
469 PHARYNGEAL SWELLING 163
470 UPPER LIMB FRACTURE 163
471 BLOOD PRESSURE SYSTOLIC INCREASED 162
472 BODY TEMPERATURE INCREASED 162
473 DERMATITIS 162
474 GLOSSODYNIA 162
475 TREATMENT FAILURE 162
476 SKIN FISSURES 161
477 INTERVERTEBRAL DISC DEGENERATION 160
478 JOINT INJURY 160
479 NASAL DRYNESS 160
480 RHINITIS ALLERGIC 160
481 CARDIO-RESPIRATORY ARREST 159
482 DEVICE DISLOCATION 159
483 INSURANCE ISSUE 159
484 CYTOKINE RELEASE SYNDROME 158
485 EAR DISCOMFORT 158
486 IMPAIRED GASTRIC EMPTYING 158
487 LYMPHOCYTE COUNT DECREASED 158
488 MUSCULOSKELETAL CHEST PAIN 158
489 SCIATICA 158
490 BLOOD SODIUM DECREASED 157
491 BLOOD UREA INCREASED 157
492 FEMUR FRACTURE 157
493 SCAR 157
494 BLINDNESS 156
495 BLOOD BILIRUBIN INCREASED 156
496 EATING DISORDER 156
497 DRUG DEPENDENCE 155
498 HYPOAESTHESIA ORAL 155
499 TEMPERATURE INTOLERANCE 155
500 ACTIVITIES OF DAILY LIVING IMPAIRED 153
501 INTERNATIONAL NORMALISED RATIO INCREASED 153
502 REBOUND ACID HYPERSECRETION 152
503 ABDOMINAL PAIN LOWER 151
504 HYPERKALAEMIA 151
505 ORAL DISCOMFORT 151
506 PERICARDIAL EFFUSION 151
507 ORAL HERPES 150
508 INTERSTITIAL LUNG DISEASE 149
509 PRODUCT ADMINISTRATION INTERRUPTED 149
510 ROTATOR CUFF SYNDROME 149
511 PALLOR 148
512 TASTE DISORDER 148
513 UNRESPONSIVE TO STIMULI 148
514 BACK DISORDER 147
515 BONE DISORDER 147
516 KIDNEY INFECTION 147
517 TENDONITIS 147
518 VISUAL ACUITY REDUCED 147
519 DEPRESSED LEVEL OF CONSCIOUSNESS 146
520 FAECES DISCOLOURED 146
521 HYPERPARATHYROIDISM SECONDARY 146
522 MOUTH ULCERATION 146
523 PAIN OF SKIN 146
524 RESPIRATORY DISTRESS 146
525 HAEMATOMA 145
526 C-REACTIVE PROTEIN INCREASED 144
527 HAEMATEMESIS 144
528 ORAL CANDIDIASIS 144
529 PROCEDURAL PAIN 144
530 PRODUCT PHYSICAL ISSUE 144
531 NOCTURIA 143
532 SECRETION DISCHARGE 143
533 SKIN ULCER 143
534 PULMONARY MASS 142
535 BACTERIAL INFECTION 141
536 DRUG EFFECT LESS THAN EXPECTED 141
537 SCRATCH 141
538 BLOOD POTASSIUM INCREASED 140
539 DELIRIUM 140
540 FEEDING DISORDER 139
541 GLAUCOMA 139
542 BODY HEIGHT DECREASED 138
543 COLITIS ULCERATIVE 138
544 CANDIDA INFECTION 137
545 DEAFNESS 137
546 INJECTION SITE MASS 137
547 ASCITES 136
548 PARANOIA 136
549 PHARMACEUTICAL PRODUCT COMPLAINT 136
550 SPUTUM DISCOLOURED 136
551 ABORTION SPONTANEOUS 135
552 FREQUENT BOWEL MOVEMENTS 135
553 GASTRIC ULCER 135
554 INITIAL INSOMNIA 135
555 THINKING ABNORMAL 135
556 FACE OEDEMA 134
557 TENDERNESS 134
558 MADAROSIS 133
559 BLOOD TRIGLYCERIDES INCREASED 132
560 COLD SWEAT 132
561 NASAL DISCOMFORT 132
562 WOUND 132
563 OROPHARYNGEAL DISCOMFORT 131
564 PHARYNGITIS 131
565 TOOTH INFECTION 131
566 ATELECTASIS 130
567 HERNIA 130
568 INCREASED APPETITE 130
569 ANOSMIA 129
570 DRUG-INDUCED LIVER INJURY 129
571 LIGAMENT SPRAIN 129
572 MITRAL VALVE INCOMPETENCE 129
573 PRODUCT USE COMPLAINT 128
574 SKIN HAEMORRHAGE 128
575 ULCER 128
576 CARDIOMEGALY 127
577 FOETAL EXPOSURE DURING PREGNANCY 127
578 RENAL CYST 127
579 BRONCHOSPASM 126
580 OSTEOMYELITIS 126
581 MOUTH HAEMORRHAGE 125
582 PELVIC PAIN 125
583 COORDINATION ABNORMAL 124
584 ERUCTATION 124
585 POST-TRAUMATIC STRESS DISORDER 124
586 QUALITY OF LIFE DECREASED 124
587 RASH MACULO-PAPULAR 124
588 BURSITIS 123
589 EPILEPSY 123
590 LOCAL SWELLING 122
591 MASS 122
592 SINUS HEADACHE 122
593 SYSTEMIC LUPUS ERYTHEMATOSUS 122
594 APHONIA 121
595 DEMENTIA 121
596 GLYCOSYLATED HAEMOGLOBIN INCREASED 121
597 HAIR DISORDER 121
598 METABOLIC ACIDOSIS 121
599 POST PROCEDURAL COMPLICATION 121
600 STEVENS-JOHNSON SYNDROME 121
601 BLOOD COUNT ABNORMAL 120
602 CHOLECYSTITIS 120
603 DIZZINESS POSTURAL 120
604 INCORRECT DRUG ADMINISTRATION DURATION 120
605 MENTAL IMPAIRMENT 120
606 PSYCHOTIC DISORDER 120
607 BIPOLAR DISORDER 119
608 DRUG ERUPTION 119
609 HUNGER 119
610 MUCOSAL INFLAMMATION 119
611 PRODUCT AVAILABILITY ISSUE 119
612 BLOOD IRON DECREASED 118
613 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 118
614 DRUG PRESCRIBING ERROR 118
615 LOWER LIMB FRACTURE 118
616 PRESCRIBED OVERDOSE 118
617 INJECTION SITE WARMTH 117
618 LEUKOCYTOSIS 117
619 MICTURITION URGENCY 117
620 GENERALISED TONIC-CLONIC SEIZURE 116
621 IMPAIRED WORK ABILITY 116
622 KNEE ARTHROPLASTY 116
623 LIVER FUNCTION TEST INCREASED 116
624 PULMONARY CONGESTION 116
625 WEIGHT FLUCTUATION 116
626 HALLUCINATION, VISUAL 115
627 OBSTRUCTIVE AIRWAYS DISORDER 115
628 PHARYNGITIS STREPTOCOCCAL 115
629 DEVICE RELATED INFECTION 114
630 FLUID OVERLOAD 114
631 PRODUCT STORAGE ERROR 114
632 SMALL INTESTINAL OBSTRUCTION 114
633 FOOD ALLERGY 113
634 GAMMA-GLUTAMYLTRANSFERASE INCREASED 113
635 GASTROENTERITIS 113
636 IMMUNODEFICIENCY 113
637 JOINT RANGE OF MOTION DECREASED 113
638 LARYNGITIS 113
639 NERVOUS SYSTEM DISORDER 113
640 PRODUCT PRESCRIBING ERROR 113
641 DIABETES MELLITUS INADEQUATE CONTROL 112
642 PULMONARY ARTERIAL HYPERTENSION 112
643 VENTRICULAR TACHYCARDIA 112
644 ARTHROPOD BITE 111
645 BLOOD MAGNESIUM DECREASED 111
646 DENTAL CARIES 111
647 RHINITIS 111
648 SKIN INFECTION 111
649 COAGULOPATHY 110
650 HEPATIC FUNCTION ABNORMAL 110
651 LUNG NEOPLASM MALIGNANT 110
652 ENCEPHALOPATHY 109
653 HYPOMAGNESAEMIA 109
654 INTENTIONAL SELF-INJURY 109
655 SENSORY DISTURBANCE 109
656 SPINAL FRACTURE 109
657 UPPER GASTROINTESTINAL HAEMORRHAGE 109
658 ABASIA 108
659 FEELING DRUNK 108
660 INCORRECT PRODUCT ADMINISTRATION DURATION 108
661 OBSESSIVE-COMPULSIVE DISORDER 108
662 BLOOD CREATINE PHOSPHOKINASE INCREASED 107
663 BLOOD TEST ABNORMAL 107
664 CARDIOMYOPATHY 107
665 DIABETIC NEUROPATHY 107
666 DRUG DOSE OMISSION BY DEVICE 107
667 EXOSTOSIS 107
668 INFUSION SITE HAEMORRHAGE 107
669 NEPHROPATHY 107
670 THYROID DISORDER 107
671 TRICUSPID VALVE INCOMPETENCE 107
672 VENTRICULAR EXTRASYSTOLES 107
673 DEVICE BREAKAGE 106
674 EXPIRED DRUG ADMINISTERED 106
675 EYE DISCHARGE 106
676 ANAPHYLACTIC SHOCK 105
677 DISABILITY 105
678 FACIAL PAIN 105
679 IRON DEFICIENCY ANAEMIA 105
680 JAUNDICE 105
681 PERIPHERAL COLDNESS 105
682 WRIST FRACTURE 105
683 BASAL CELL CARCINOMA 104
684 CORONARY ARTERY OCCLUSION 104
685 MUSCULOSKELETAL DISORDER 104
686 SOMNAMBULISM 104
687 CHRONIC SINUSITIS 103
688 ERECTILE DYSFUNCTION 103
689 EXPOSURE VIA SKIN CONTACT 103
690 IMMUNE SYSTEM DISORDER 103
691 MULTIPLE FRACTURES 103
692 CHOLECYSTECTOMY 102
693 CONTRAINDICATED PRODUCT ADMINISTERED 102
694 NEOPLASM PROGRESSION 102
695 SPLENOMEGALY 102
696 TOOTH LOSS 102
697 INFUSION SITE PRURITUS 101
698 CHRONIC SPONTANEOUS URTICARIA 100
699 CYST 100
700 DEVICE LEAKAGE 100
701 DRUG EXPOSURE DURING PREGNANCY 100
702 SINUS TACHYCARDIA 100
703 SKIN CANCER 100
704 SLUGGISHNESS 100
705 PLATELET COUNT INCREASED 99
706 SPINAL DISORDER 99
707 TARDIVE DYSKINESIA 99
708 DECREASED ACTIVITY 98
709 HEMIPARESIS 98
710 HEPATITIS 98
711 PSYCHOLOGICAL TRAUMA 98
712 INCREASED TENDENCY TO BRUISE 97
713 LUNG INFECTION 97
714 MUSCLE STRAIN 97
715 RENAL PAIN 97
716 SKIN LACERATION 97
717 VITAMIN D DECREASED 97
718 DEVICE FAILURE 96
719 EYE HAEMORRHAGE 96
720 FLANK PAIN 96
721 OSTEONECROSIS 96
722 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 96
723 SCAB 96
724 SUPRAVENTRICULAR TACHYCARDIA 96
725 VITREOUS FLOATERS 96
726 EYE INFECTION 95
727 MALNUTRITION 95
728 MENSTRUATION IRREGULAR 95
729 BLOOD CALCIUM DECREASED 94
730 NEUTROPHIL COUNT INCREASED 94
731 OSTEONECROSIS OF JAW 94
732 FOOT DEFORMITY 93
733 HOSPICE CARE 93
734 MAJOR DEPRESSION 93
735 ORTHOSTATIC HYPOTENSION 93
736 PANCREATITIS ACUTE 93
737 CEREBRAL HAEMORRHAGE 92
738 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 92
739 FRUSTRATION TOLERANCE DECREASED 92
740 NERVE COMPRESSION 92
741 RENAL TUBULAR NECROSIS 92
742 ABSCESS 91
743 CARDIAC MURMUR 91
744 DIABETIC KETOACIDOSIS 91
745 EJECTION FRACTION DECREASED 91
746 MAST CELL ACTIVATION SYNDROME 91
747 PNEUMOTHORAX 91
748 PRODUCT PACKAGING ISSUE 91
749 TOXIC EPIDERMAL NECROLYSIS 91
750 DELUSION 90
751 DERMATITIS ALLERGIC 90
752 EYELID OEDEMA 90
753 FULL BLOOD COUNT ABNORMAL 90
754 RESPIRATORY ARREST 90
755 SARS-COV-2 TEST POSITIVE 90
756 TOOTH ABSCESS 90
757 APPLICATION SITE ERYTHEMA 89
758 BLADDER DISORDER 89
759 CEREBRAL INFARCTION 89
760 DIVERTICULUM 89
761 PARANASAL SINUS DISCOMFORT 89
762 ASPIRATION 88
763 NEEDLE ISSUE 88
764 PRODUCT ADMINISTRATION ERROR 88
765 RHABDOMYOLYSIS 88
766 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 88
767 ESSENTIAL HYPERTENSION 87
768 OCULAR DISCOMFORT 87
769 TOOTH FRACTURE 87
770 CARDIOVASCULAR DISORDER 86
771 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 86
772 MANIA 86
773 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86
774 NODULE 86
775 DECUBITUS ULCER 85
776 EMPHYSEMA 85
777 INCORRECT DOSAGE ADMINISTERED 85
778 MENORRHAGIA 85
779 PRODUCT PACKAGE ASSOCIATED INJURY 85
780 SCOLIOSIS 85
781 SKIN PLAQUE 85
782 CONCUSSION 84
783 ADRENAL INSUFFICIENCY 83
784 BACK INJURY 83
785 BODY TEMPERATURE DECREASED 83
786 NO THERAPEUTIC RESPONSE 83
787 SNORING 83
788 METASTASES TO BONE 82
789 OESOPHAGITIS 82
790 PULMONARY THROMBOSIS 82
791 VENTRICULAR FIBRILLATION 82
792 ANAL INCONTINENCE 81
793 HEPATIC FAILURE 81
794 HIP ARTHROPLASTY 81
795 HYPOCALCAEMIA 81
796 MENISCUS INJURY 81
797 PARALYSIS 81
798 RALES 81
799 SKIN WARM 81
800 BLOOD ALBUMIN DECREASED 80
801 BREAST PAIN 80
802 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 80
803 MOUTH SWELLING 80
804 POOR QUALITY DRUG ADMINISTERED 80
805 RESPIRATORY RATE INCREASED 80
806 SALIVARY HYPERSECRETION 80
807 CYANOSIS 79
808 EUPHORIC MOOD 79
809 THERMAL BURN 79
810 ADVERSE REACTION 78
811 HEPATIC CIRRHOSIS 78
812 HYPERCHOLESTEROLAEMIA 78
813 HYSTERECTOMY 78
814 INFUSION SITE INFECTION 78
815 LACERATION 78
816 MUSCLE ATROPHY 78
817 NERVE INJURY 78
818 PAPULE 78
819 SENSATION OF FOREIGN BODY 78
820 SHOCK 78
821 SKIN SWELLING 78
822 GASTROINTESTINAL INFECTION 77
823 INFUSION SITE DISCHARGE 77
824 RESPIRATORY SYNCYTIAL VIRUS INFECTION 77
825 RHINOVIRUS INFECTION 77
826 BOWEL MOVEMENT IRREGULARITY 76
827 DEVICE DELIVERY SYSTEM ISSUE 76
828 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 76
829 PARKINSON^S DISEASE 76
830 PETECHIAE 76
831 PREGNANCY 76
832 RED BLOOD CELL SEDIMENTATION RATE INCREASED 76
833 RENAL FAILURE CHRONIC 76
834 BREAST CANCER FEMALE 75
835 CHOLECYSTITIS ACUTE 75
836 ENERGY INCREASED 75
837 IMPAIRED DRIVING ABILITY 75
838 LACTIC ACIDOSIS 75
839 PERIORBITAL OEDEMA 75
840 PRODUCT ADHESION ISSUE 75
841 SENSORY LOSS 75
842 COVID-19 PNEUMONIA 74
843 DEVICE EXPULSION 74
844 GINGIVAL BLEEDING 74
845 INCONTINENCE 74
846 OVERWEIGHT 74
847 PULMONARY FIBROSIS 74
848 WALKING AID USER 74
849 BLOOD GLUCOSE ABNORMAL 73
850 GENERALISED OEDEMA 73
851 INCREASED UPPER AIRWAY SECRETION 73
852 INFLAMMATORY BOWEL DISEASE 73
853 ONYCHOCLASIS 73
854 PNEUMONIA BACTERIAL 73
855 PURPURA 73
856 TOOTH EXTRACTION 73
857 APPLICATION SITE PAIN 72
858 CLOSTRIDIUM DIFFICILE COLITIS 72
859 ELECTROCARDIOGRAM ABNORMAL 72
860 HALLUCINATION, AUDITORY 72
861 MYDRIASIS 72
862 OVARIAN CYST 72
863 PRESCRIBED UNDERDOSE 72
864 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 72
865 TRANSFUSION 72
866 GASTROINTESTINAL PAIN 71
867 MACULAR DEGENERATION 71
868 METRORRHAGIA 71
869 PROSTATE CANCER 71
870 UROSEPSIS 71
871 BACTERAEMIA 70
872 COMPLICATION ASSOCIATED WITH DEVICE 70
873 DEVICE OCCLUSION 70
874 DYSLIPIDAEMIA 70
875 EXTRAPYRAMIDAL DISORDER 70
876 INJECTION SITE DISCOLOURATION 70
877 ODYNOPHAGIA 70
878 SENSITIVE SKIN 70
879 SWELLING OF EYELID 70
880 BEDRIDDEN 69
881 DEVICE USE ERROR 69
882 ELECTROLYTE IMBALANCE 69
883 EOSINOPHIL COUNT INCREASED 69
884 ILEUS 69
885 INFUSION SITE EXTRAVASATION 69
886 LOWER GASTROINTESTINAL HAEMORRHAGE 69
887 PERSONALITY CHANGE 69
888 SPINAL COMPRESSION FRACTURE 69
889 SPINAL PAIN 69
890 SUBDURAL HAEMATOMA 69
891 VITAMIN B12 DEFICIENCY 69
892 WRONG DRUG ADMINISTERED 69
893 AFFECTIVE DISORDER 68
894 ARTERIOSCLEROSIS 68
895 CHOLESTASIS 68
896 HAND FRACTURE 68
897 HUMAN RHINOVIRUS TEST POSITIVE 68
898 PATIENT DISSATISFACTION WITH TREATMENT 68
899 TACHYPNOEA 68
900 UTERINE LEIOMYOMA 68
901 DYSTONIA 67
902 GRIP STRENGTH DECREASED 67
903 HAEMOGLOBIN INCREASED 67
904 HEREDITARY ANGIOEDEMA 67
905 LEFT VENTRICULAR DYSFUNCTION 67
906 LIVER INJURY 67
907 SCREAMING 67
908 TORSADE DE POINTES 67
909 TRANSAMINASES INCREASED 67
910 VASCULITIS 67
911 ANXIETY DISORDER 66
912 COELIAC DISEASE 66
913 DRUG SCREEN POSITIVE 66
914 EXERCISE TOLERANCE DECREASED 66
915 HYPERURICAEMIA 66
916 LIBIDO DECREASED 66
917 LIP DRY 66
918 TONGUE DISORDER 66
919 BREAST MASS 65
920 CYSTIC FIBROSIS 65
921 DEVICE DIFFICULT TO USE 65
922 DRUG ABUSE 65
923 HYPERVOLAEMIA 65
924 JOINT DISLOCATION 65
925 LYMPHOEDEMA 65
926 MELAENA 65
927 SPINAL OPERATION 65
928 SYNOVITIS 65
929 THERAPY PARTIAL RESPONDER 65
930 TONGUE BITING 65
931 WOUND INFECTION 65
932 ARTERIOSCLEROSIS CORONARY ARTERY 64
933 AUTOIMMUNE DISORDER 64
934 BLINDNESS UNILATERAL 64
935 DYSMENORRHOEA 64
936 GINGIVAL PAIN 64
937 GLOMERULAR FILTRATION RATE DECREASED 64
938 INCORRECT ROUTE OF DRUG ADMINISTRATION 64
939 MENSTRUAL DISORDER 64
940 MUSCLE SPASTICITY 64
941 OTITIS MEDIA 64
942 PARANASAL SINUS HYPERSECRETION 64
943 TENDON RUPTURE 64
944 ANOREXIA 63
945 APPLICATION SITE PRURITUS 63
946 ASTHMATIC CRISIS 63
947 ATAXIA 63
948 CAESAREAN SECTION 63
949 DEVICE INFUSION ISSUE 63
950 GLUCOSE TOLERANCE IMPAIRED 63
951 LUNG INFILTRATION 63
952 MONOCYTE COUNT INCREASED 63
953 PROTEINURIA 63
954 SEROTONIN SYNDROME 63
955 BLOOD LACTATE DEHYDROGENASE INCREASED 62
956 DECREASED IMMUNE RESPONSIVENESS 62
957 EYE INFLAMMATION 62
958 FRACTURE 62
959 JOINT EFFUSION 62
960 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 62
961 MUSCLE DISORDER 62
962 PRODUCT DISTRIBUTION ISSUE 62
963 PRODUCT ODOUR ABNORMAL 62
964 TENSION HEADACHE 62
965 WHITE BLOOD CELL COUNT ABNORMAL 62
966 ALTERED STATE OF CONSCIOUSNESS 61
967 ATRIAL FLUTTER 61
968 BLOOD THYROID STIMULATING HORMONE INCREASED 61
969 EAR CONGESTION 61
970 HICCUPS 61
971 NASAL POLYPS 61
972 POST PROCEDURAL INFECTION 61
973 SUNBURN 61
974 APATHY 60
975 BRAIN OEDEMA 60
976 EXTRASYSTOLES 60
977 GROIN PAIN 60
978 HYPERCALCAEMIA 60
979 POLYP 60
980 POSTOPERATIVE WOUND INFECTION 60
981 PRODUCT DISPENSING ERROR 60
982 PSEUDOMONAS INFECTION 60
983 STREPTOCOCCAL INFECTION 60
984 BRUXISM 59
985 CENTRAL NERVOUS SYSTEM LESION 59
986 DIVERTICULUM INTESTINAL 59
987 ENURESIS 59
988 EOSINOPHILIA 59
989 INTRAOCULAR PRESSURE INCREASED 59
990 NON-CARDIAC CHEST PAIN 59
991 ORAL DISORDER 59
992 PAROSMIA 59
993 PSYCHIATRIC SYMPTOM 59
994 RIGHT VENTRICULAR FAILURE 59
995 URINE OUTPUT DECREASED 59
996 HEPATOMEGALY 58
997 INJECTION SITE NODULE 58
998 LYMPHOMA 58
999 METASTASES TO LIVER 58